<b>Recruitment for the SWEET Study is now closed.</b>

Watch our recruitment animation below.   

<div style="padding:56.25% 0 0 0;position:relative;"><iframe src="https://player.vimeo.com/video/1045043958?badge=0&amp;autopause=0&amp;player_id=0&amp;app_id=58479"                                             style="position:absolute;top:0;left:0;width:100%;height:100%;" frameborder="0" allow="autoplay; fullscreen; picture-in-picture" allowfullscreen></iframe></div><script src="https://player.vimeo.com/api/player.js"></script>

<div style="padding:56.25% 0 0 0;position:relative;"><iframe src="https://player.vimeo.com/video/1045041824?badge=0&amp;autopause=0&amp;player_id=0&amp;app_id=58479" style="position:absolute;top:0;left:0;width:100%;height:100%;" frameborder="0" allow="autoplay; fullscreen; picture-in-picture" allowfullscreen></iframe></div><script src="https://player.vimeo.com/api/player.js"></script>

Eligibility Criteria:

- Are Aged 18+
- Are Female
- Have had a diagnosis of ER positive invasive breast cancer, stages 1-3, treated with curative intent
- Are within <b>3 months of first oral AET prescription</b> (tamoxifen or aromatase inhibitor)
- Have completed surgery to remove breast cancer
- Have completed chemotherapy (if applicable)
- Can access the internet and have an email address; and
- Are willing to receive a support package with a web-based component.


To contact the SWEET research team for general queries about SWEET you can contact the team on:  [SWEET@warwick.ac.uk ](mailto:SWEET@warwick.ac.uk)

